Thank you West Coast Oncology and OncologyEducation for inviting me to give the 2024 Keynote on Sarcoma updates!!

A huge shout out 📢 to #oncology team at #SarawakGeneralHospital in #Kuching #Malaysia 🇲🇾 esp. Dr PJ Voon for being such gracious hosts to ASCO #AsiaPacific #RegionalCouncil these last 2 days! Super dedicated staff with lots of #meaningful initiatives taking place here!…

Great to meet @asco Leadership Development Program graduate Jarushka Naidoo at #EuroAmericanCancerForum2024 -
Now a leader in lung cancer
in Ireland. #CancerHasNoBorders #TogetherStronger

Wonderful PhD opportunity in Glasgow with a brilliant supervisor and a great team. Intriguing topic too…RadNetCRUKGlasgow UofG Cancer Sciences Cancer Research UK in Scotland

🌟Let's celebrate Dr. Mark Gaze for his exceptional achievement in winning the prestigious #JohannVisser Award at the #CCLGMemberAwards ! 🏆A great mentor to many, his commitment has made a particular impact in sarcoma and neuroblastoma. Thank you for your dedication 👏 #CCLG2024

Congratulations to our CMO Julie Gralow on receiving an award for her key leadership in global cancer control presented at #EuroAmericanCancerForum2024 by Michael Clausen, Deputy Chief of Mission, U.S. Embassy Dublin. #StrongerTogether

Leiomyosarcoma is a form of #sarcoma that grows in the smooth, involuntary muscles found in blood vessels, digestive and urinary systems, the uterus, and other areas. It’s one of the more common subtypes of sarcoma, making up 10% to 20% of all soft tissue sarcomas.…

Drugs targeting TBXT (brachyury) are needed for chordoma and may benefit other cancers too. But developing them is currently tough. To make it easier Chordoma Foundation Labs is creating a set of capabilities to minimize the time, cost and risk involved. Here’s one, more to come.

Kicked off ASCO #AsiaPacific #RegionalCouncil meeting in #Kuching #Sarawak 🇲🇾 w/ dedicated council members representing our region and #ASCOStaff . Happy to #vett & #deliver specific initiatives which will benefit #oncology landscape in our region. Roselle De Guzman Melvin LK CHUA…

In the last few days, my favorite and most impactful quote has been....'don't get between an oncologist and a diagnostic test'.....

Now out in Cancer Research: We mine the epigenetic underpinnings of #AlveolarSoftPartSarcoma utilizing patient samples, preclinical models, and functional tags (dTAG, BioID) to define the oncogenic transcriptional program driven by ASPSCR1::TFE3 and actionable therapeutic liabilities:

Our Immune Oncology Research Institute spotlighted in ASCO policy statement on global equity in clinical trials! 🌟
With Armenia’s 1st oncology trials, we’re making our way to this global fight against cancer “Who if not us, will take these first steps?”
Gevorg Tamamyan Shushan Hovsepyan Elen

Very nice to be recognized as an author of a top cited paper Wiley, for our publication on the tissue-agnostic potential of ADCS American Cancer Society Paolo Tarantino

Celebrating being appointed as a Medical Oncology Consultant specialising in sarcoma and melanoma. Thank you to everyone who has supported me over the past 15 years🥂

'Charlie and I found Sarcoma UK’s Support Line amazingly helpful and used it frequently.'

It is truly humbling to witness the outpouring of support from Thandi and the 18-strong Team Chazza.
We wish all of them the very best of luck!

london-tv.co.uk/team-chazza-pr…

Yesterday, our group leader César Serrano García was awarded a CRIS contra el cáncer 'Program of Excellence' award. We are very happy and looking forward to continue our research in GIST and sarcomas! #SarcomaResearch

Pleased to support Cancer52’s manifesto for rare and less common cancers, and its 3 key asks: To reduce mortality and health inequalities, increase early diagnosis, and put patients at the core of a new national mission on rare and less common cancers #C52Manifesto Sarcoma UK

Stimulating & fruitful discussion this morning at Italian Sarcoma Group Annual Meeting on the new neoad study - can’t wait for the next steps!
Dario Callegaro Sandro Pasquali ChiaraFabbroni

A whirlwind trip ✈️ to #Taipei to attend #TASLC co-organised #ConversationsInOncology meeting. We provided updates on all aspects of drug development in #NSCLC . Cannot leave w/o slotting in some local beef noodles 🍜😋👍- even if it had to be at the airport 😂 #LCSM CUHK Medicine

Should we use mifamurtide only in high-risk localized #osteosarcoma pts?
Define high-risk!!! Italian Sarcoma Group
#Roma #osteosarcoma #mifamurtide #ISGOS2 #GEIS33 #tumormicroenvironment #cancerpredisposition Javier Martin Broto Rizzoli IRCCS GEIS
Palma Dileo Takeda